Urethral Neoplasms
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer (NCT03288545) | Astellas Pharma Global Development, Inc. | 2017-10-11 |
| A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (NCT03219333) | Astellas Pharma Inc | 2017-10-08 |
| LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer (NCT02612194) | Wake Forest University Health Sciences | 2016-09-27 |
| Cabozantinib for Advanced Urothelial Cancer (NCT01688999) | National Cancer Institute (NCI) | 2012-09-11 |
| Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors (NCT01352962) | National Cancer Institute (NCI) | 2011-09-26 |
| TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium (NCT00077688) | Achieve Life Sciences | 2003-11-01 |
Track Urethral Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.